Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,1613,180 of 20,252 grants

Active RESEARCH CENTERS
Bioinformatics Core
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2023 – 2027

Bioinformatics Core Project Summary All forms of the incurable plasma cell malignancies, multiple myeloma (MM), and Waldenstrom’s macroglobulinemia (WM) emerge from a precursor con...

Active OTHER RESEARCH-RELATED
Examining the Role of RNF168 Activity in BRCA1 Mutant Cancers
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT My career goal is to develop an independent research program focused on DNA damage signaling and how it can be exploited for the treatment of cancer. The w...

$1.55M
USD
Active RESEARCH CENTERS
Washington University (WU) ROBIN Center: MicroEnvironment and Tumor Effects Of Radiotherapy (METEOR)
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

Project Summary In addition to direct killing of rapidly proliferating tumor cells, radiation therapy (RT) modifies tumor immunity. RT increases the expression and release of tumor...

$14.77M
USD
Active RESEARCH CENTERS
METEOR Administrative Core
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

ADMINISTRATIVE CORE SUMMARY Critical to the success of the Washington University (WU) ROBIN “MicroEnvironment Tumor Effects Of Radiotherapy” (METEOR) Center is a structured approac...

Active RESEARCH CENTERS
METEOR-Comprehensive Radiobiology Assessment TRial (METEOR-CRATR)
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

MOLECULAR CHARACTERIZATION TRIAL SUMMARY The standard of care (SOC) for locally advanced cervical cancer, pelvic radiation (RT) with concurrent cisplatin, is associated with a 30-5...

Active RESEARCH CENTERS
Research Project Cervical Cancer
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

PROJECT 1 SUMMARY (CERVIX) The standard of care (SOC) for locally advanced cervical cancer, pelvic radiation (RT) with concurrent cisplatin, is associated with a 30-50% failure rat...

Active RESEARCH CENTERS
Research Project Pancreatic Cancer
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

PROJECT 2 (PANCREAS) SUMMARY The prognosis for pancreatic ductal adenocarcinomas (PDAC) patients is dismal. Unfortunately, attempts at immunotherapy for PDAC to date have not achie...

Active NON-SBIR/STTR RPGS
Project 3: Skin hypoxia, MCPyV infection, and MCC tumorigenesis
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

Project Abstract Merkel cell carcinoma (MCC) is one of the most aggressive skin cancers. Clonal integration of Merkel cell polyomavirus (MCPyV) genome into the host DNA has been ob...

Active NON-SBIR/STTR RPGS
Project 4: Regulation of EBV Latency and Oncogenesis by Hypoxia
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

Abstract: Epstein-Barr Virus (EBV) a human gammaherpesvirus that is associated with diverse lymphoid and epithelial malignancies. Like all cancers, EBV-associated cancers must comp...

Active NON-SBIR/STTR RPGS
Administrative Core
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

Abstract Core A: Program Administration The mission of the Administrative core is to maintain a cohesive program through facilitating interactions between the three projects and th...

Active NON-SBIR/STTR RPGS
Virus, Vector and Cell Culture Core
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

Abstract Core B: Virus Vector and Cell Culture Core The Virus Vector and Cell Culture Core (VVCCC) will be responsible for 1) recombinant virus design consultation, 2) vector and v...

Active OTHER RESEARCH-RELATED
Generating Research Opportunities Within Statistics at Fred Hutch (GROWS@FredHutch)
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2023 – 2028

Project Summary/Abstract In cancer research, the need for a diverse pool of researchers in statistics and data science has never been greater. Yet, the requisite academic pipeline...

$1.74M
USD
Active NON-SBIR/STTR RPGS
Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Chimeric antigen receptor T cell therapy (CARTx) has transformed treatment for B cell malignancies. However, the effects of CARTx on humoral immunity and i...

$8.59M
USD
Active NON-SBIR/STTR RPGS
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression: A double-blind randomized controlled trial
NATIONAL CANCER INSTITUTE University of Utah United States 2023 – 2028

ABSTRACT The incidence of metastatic prostate cancer has increased 3% per year since 2012, and the survival rate is only 29%. Muscle mass is important for metastatic prostate cance...

$6.51M
USD
Active NON-SBIR/STTR RPGS
Multi-omics for obesity-associated liver disease discovery in Hispanics/Latinos: the Cameron County Hispanic Cohort
NATIONAL CANCER INSTITUTE University of Texas Hlth Sci Ctr Houston United States 2023 – 2028

ABSTRACT We submit “Multi-omics for obesity-associated liver disease discovery in Hispanics/Latinos: the Cameron County Hispanic Cohort” (hereafter CCHC-Liver) in response to RFA-H...

$7.58M
USD
Active NON-SBIR/STTR RPGS
Impact of TNF on Oncolytic Virotherapy
NATIONAL CANCER INSTITUTE University of New Mexico Health Scis Ctr United States 2023 – 2028

Project Summary: Oncolytic virotherapy (OV) represents a novel method to treat a variety of solid tumors by inducing anti-tumor immune responses. While this therapy has been extrem...

$4.16M
USD
Active NON-SBIR/STTR RPGS
Epstein Barr Virus Driven Mechanisms of Post Transplant Lymphoproliferative Disease
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Epstein Barr virus (EBV) is a broadly disseminated gammaherpes virus that, in immunosuppressed or immunocompromised individuals, can cause serious, life-th...

$5.97M
USD
Active TRAINING, INSTITUTIONAL
Pediatric and Adult Translational Cancer Drug Discovery and Development Training Program (PACT-D3)
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2023 – 2028

Abstract This training program is unique for our institution, creating the next generation of basic and clinical investigators who focus their efforts on strategic and comprehensiv...

$1.64M
USD
Active OTHER RESEARCH-RELATED
Cancer Adoptive Cell Therapy (Can-ACT) Network Coordinating Center at Mayo Clinic
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT – NETWORK COORDINATING CENTER The Network Coordinating Center (NCC) will facilitate and be responsible for network-wide coordination and harmonization of s...

$4.56M
USD
Active NON-SBIR/STTR RPGS
Local Tumoral Delivered Immune Checkpoint Blockades Immunotherapy and Radioembolization Combination Therapy
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2023 – 2028

PROJECT SUMMARY Systemic mono- or combination- immune checkpoint blockade (ICB) immunotherapy has been an established therapeutic paradigm. However, a risk of serious autoimmune si...

$3.39M
USD